RxSight, Inc.
RXST
$5.55
$0.030.54%
NASDAQ
| 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | |
|---|---|---|---|---|---|
| Net Income | -93.94% | -54.13% | -54.88% | -93.88% | 10.00% |
| Total Depreciation and Amortization | 6.24% | 79.54% | -25.15% | -5.37% | -31.14% |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 28.66% | 39.70% | 51.47% | 87.06% | 44.79% |
| Change in Net Operating Assets | 67.91% | 116.59% | -6.48% | 64.53% | -33.48% |
| Cash from Operations | -23.31% | 73.80% | -282.62% | -8.67% | 5.12% |
| Capital Expenditure | -32.00% | -34.24% | 47.33% | -0.92% | 70.77% |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -55.17% | -491.19% | -3.26% | 114.19% | -18.33% |
| Cash from Investing | -57.57% | -828.33% | 2.76% | 112.67% | -14.09% |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | 46.15% | 175.00% | -72.73% | 72.73% | 51.85% |
| Issuance of Common Stock | -79.31% | -64.66% | -96.58% | -98.15% | -93.14% |
| Repurchase of Common Stock | 66.64% | -- | 75.64% | -- | 33.55% |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | -- | -- |
| Cash from Financing | 54.29% | -64.28% | -160.36% | -98.15% | -109.20% |
| Foreign Exchange rate Adjustments | -50.00% | -25.00% | -128.57% | 1,500.00% | 300.00% |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -121.04% | -40,445.83% | -38.81% | 250.67% | -50.80% |